Lymphokine-activated killer (LAK) cells are generated by the culture of peripheral blood lymphocytes with interleukin-2 (IL-2). A variety of cells, including T-lymphocytes and natural killer (NK) cells, can be activated by IL-2 to exhibit the ability to kill multiple tumor and "modified-self" target
โฆ LIBER โฆ
Establishment of Mouse Lymphokine-activated Killer Cell Clones and Their Properties
โ Scribed by Kato, Kazunori ;Sato, Naoko ;Tanabe, Toshifumi ;Yagita, Hideo ;Agatsutna, Toshinori ;Hashimoto, Yoshiyuki
- Book ID
- 108579311
- Publisher
- Wiley (Blackwell Publishing)
- Year
- 1991
- Tongue
- English
- Weight
- 449 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0910-5050
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Phenotypic and functional analysis of ly
โ
Anita S. -F. Chong; Alexandre Aleksijevic; Philip Scuderi; Evan M. Hersh; Willia
๐
Article
๐
1989
๐
Springer-Verlag
๐
English
โ 945 KB
Cloning of IL-2-induced human lymphokine
Cloning of IL-2-induced human lymphokine-activated killer (LAK) cells and their clinical utilization
โ
Ning Mao; Pei-Hsien Tang; Min-Wei Zhang; Fei-Zi Jiang; De-Lin Du
๐
Article
๐
1991
๐
AlphaMed Press
๐
English
โ 66 KB
Differential lysis of tumor target cells
โ
Pamela Bean; Ravin Agah; Amilabha Mazumder
๐
Article
๐
1992
๐
AlphaMed Press
๐
English
โ 482 KB
Technical aspects of lymphokine-activate
โ
C. S. Carter; S. F. Leitman; H. Cullis; L. M. Muul; K. Nason-Burchenal; S. A. Ro
๐
Article
๐
1988
๐
John Wiley and Sons
๐
English
โ 655 KB
Adoptive immunotherapy is a novel approach to treating patients with cancer, utilizing as therapy a patient's own peripheral blood lymphocytes that have been activated by incubation with interleukin-2 (IL-2). These cells develop the ability to mediate tumor regression in vivo and are referred to as
Lymphokine-activated killer cells in rat
โ
Mariana Sarneva; Nikola L. Vujanovic; M.R.M. van den Brink; Ronald B. Herberman;
๐
Article
๐
1989
๐
Elsevier Science
๐
English
โ 706 KB
Lymphokine-activated killer cell and int
โ
Alexander M.M. Eggermont; Paul H. Sugarbaker
๐
Article
๐
1987
๐
Elsevier Science
๐
English
โ 766 KB